Serum selenium and peripheral arterial disease: Results from the national health and nutrition examination survey, 2003-2004

American Journal of Epidemiology

Volumn 169, Issue 8, 2009, Pages 996-1003

  Bleys, Joachim ^a,c   Navas Acien, Ana ^a,c   Laclaustra, Martin ^a,c,d   Pastor Barriuso, Roberto ^e   Menke, Andy ^a,c   Ordovas, Jose ^f   Stranges, Saverio ^g   Guallar, Eliseo ^a,b,c,d  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c JOHNS HOPKINS UNIVERSITY   (United States)

^d CENTRO NACIONAL DE INVESTIGACIONES CARDIOVASCULARES CNIC   (Spain)

^e CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^f TUFTS UNIVERSITY   (United States)

^g UNIVERSITY OF WARWICK   (United Kingdom)

Author keywords

Antioxidants; Cardiovascular diseases; Cross sectional studies; Nutrition surveys; Peripheral vascular diseases; Selenium

Indexed keywords

C REACTIVE PROTEIN; COTININE; SELENIUM; CHOLESTEROL; LOW DENSITY LIPOPROTEIN;

ANTIOXIDANT; BLOOD; CARDIOVASCULAR DISEASE; DISEASE; HEALTH IMPACT; HEALTH RISK; HEALTH SURVEY; NUMERICAL MODEL; NUTRITION; REGRESSION ANALYSIS; SELENIUM;

ADULT; AGE DISTRIBUTION; ANKLE BRACHIAL INDEX; ARTERY DISEASE; ARTICLE; CARDIOVASCULAR RISK; CONTROLLED STUDY; ETHNICITY; FEMALE; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; MALE; MASS SPECTROMETRY; NUTRITION; PREVALENCE; RACE DIFFERENCE; SEX DIFFERENCE; BLOOD; BODY MASS; CROSS-SECTIONAL STUDY; GLOMERULUS FILTRATION RATE; METABOLISM; MIDDLE AGED; PERIPHERAL VASCULAR DISEASE; REGRESSION ANALYSIS; RISK; UNITED STATES;

NORTH AMERICA; UNITED STATES;

ADULT; BODY MASS INDEX; C-REACTIVE PROTEIN; CHOLESTEROL; CROSS-SECTIONAL STUDIES; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; LIPOPROTEINS, LDL; MALE; MIDDLE AGED; NUTRITION SURVEYS; ODDS RATIO; PERIPHERAL VASCULAR DISEASES; PREVALENCE; REGRESSION ANALYSIS; SELENIUM; UNITED STATES;

EID: 63649101852     PISSN: 00029262     EISSN: 14766256     Source Type: Journal    
DOI: 10.1093/aje/kwn414     Document Type: Article

References (49)

1. Rayman MP. Food-chain selenium and human health: emphasis on intake. Br J Nutr. 2008;100(2):254-268.
2. Navas-Acien A, Bleys J, Guallar E. Selenium intake and cardiovascular risk: what is new? Curr Opin Lipidol. 2008; 19(1):43-49.
3. Flores-Mateo G, Navas-Acien A, Pastor-Barriuso R, et al. Selenium and coronary heart disease: a meta-analysis. Am J Clin Nutr. 2006;84(4):762-773.
4. Food and Nutrition Board, Institute of Medicine. Dietary Reference Intakes for Vitamin C, Vitamin E, Selenium, and Carotenoids. A report of the Panel on Dietary Antioxidants and Related Compounds, Subcommittees on Upper Reference Levels of Nutrients and Interpretation and Uses of Dietary Reference Intakes, and the Standing Committee on the Scientific Evaluation of Dietary Reference Intakes. Washington, DC: The National Academies Press; 2000.
5. Rayman MP. Selenium in cancer prevention: a review of the evidence and mechanism of action. Proc Nutr Soc. 2005; 64(4):527-542.
6. Salvini S, Hennekens CH, Morris JS, et al. Plasma levels of the antioxidant selenium and risk of myocardial infarction among U.S. physicians. Am J Cardiol. 1995;76(17): 1218-1221.
7. Yoshizawa K, Ascherio A, Morris JS, et al. Prospective study of selenium levels in toenails and risk of coronary heart disease in men. Am J Epidemiol. 2003;158(9):852-860.
8. Bleys J, Navas-Acien A, Guallar E. Serum selenium levels and all-cause, cancer, and cardiovascular mortality among US adults. Arch Intern Med. 2008;168(4):404-410.
9. McDermott MM, Liu K, Criqui MH, et al. Ankle-brachial index and subclinical cardiac and carotid disease: the Multi-Ethnic Study of Atherosclerosis. Am J Epidemiol. 2005; 162(1):33-41.
10. Murabito JM, Evans JC, Larson MG, et al. The ankle-brachial index in the elderly and risk of stroke, coronary disease, and death: the Framingham Study. Arch Intern Med. 2003; 163(16): 1939-1942.
11. Newman AB, Shemanski L, Manolio TA, et al. Ankle-arm index as a predictor of cardiovascular disease and mortality in the Cardiovascular Health Study. The Cardiovascular Health Study Group. Arterioscler Thromb Vasc Biol. 1999;19(3): 538-545.
12. Ondrus P, Alberty R, Vassanyiova Z. Importance of lipid per-oxidation, protective enzymes and trace elements in chronic leg ischaemia. Eur J Clin Chem Clin Biochem. 1996;34(6): 471-475.
13. Mansoor MA, Bergmark C, Haswell SJ, et al. Correlation between plasma total homocysteine and copper in patients with peripheral vascular disease. Clin Chem. 2000;46(3): 385-391.
14. Hirsch AT, Haskal ZJ, Hertzer NR, et al. ACC/AHA 2005 Practice Guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesen-teric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease): endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; Trans Atlantic Inter-Society Consensus; and Vascular Disease Foundation. Circulation. 2006;113(11): e463-e654.
15. Fowkes FG, Murray GD, Butcher I, et al. Ankle brachial index combined with Framingham Risk Score to predict cardiovascular events and mortality: a meta-analysis. JAMA. 2008; 300(2): 197-208.
16. National Center for Health Statistics, Centers for Disease Control and Prevention. National Health and Nutrition Examination Survey, 2003-2004. 2007. (http://www.cdc.gov/nchs/about/major/nhanes/nhanes2003-2004/nhanes03-04.htm). (Accessed August 24, 2008).
17. National Center for Health Statistics, Centers for Disease Control and Prevention. NHANES 2003-2004 Data Documentation. Laboratory Assessment: Lab 39 - Erythrocyte Protoporphyrin and Selenium. 2007. (http://www.cdc.gov/nchs/data/ nhanes/nhanes-03-04/l39epp-c.pdf). (Accessed August 24, 2008).
18. National Center for Health Statistics, Centers for Disease Control and Prevention. NHANES 2003-2004 Data Documentation. Exam Component: Ankle-Brachial Blood Pressure Index (ABPI) Section of the Lower Extremity Disease Examination (LEXAB-C). 2005. (http://www.cdc.gov/nchs/data/nhanes/nhanes-03-04/lexab-c.pdf). (Accessed August 24, 2008).
19. Levey AS, Coresh J, Greene T, et al. Using standardized serum creatinine values in the Modification of Diet in Renal Disease Study equation for estimating glomerular filtration rate. Ann Intern Med. 2006;145(4):247-254.
20. Greenland S. Dose-response and trend analysis in epidemiology: alternatives to categorical analysis. Epidemiology. 1995; 6(4):356-365.
21. R Development Core Team. R: A Language and Environment for Statistical Computing. Vienna, Austria: R Foundation for Statistical Computing; 2008. (ISBN 3-900051-07-0). (http://www.R-project.org).
22. Lumley T. The Survey Package. (http://cran.fhcrc.org/web/packages/ survey/survey.pdf). (Accessed August 24, 2008).
23. Combs GF Jr. Selenium in global food systems. Br J Nutr. 2001;85(5):517-547.
24. Rayman MP. The importance of selenium to human health. Lancet. 2000;356(9225):233-241.
25. Salonen JT, Alfthan G, Huttunen JK, et al. Association between cardiovascular death and myocardial infarction and serum selenium in a matched-pair longitudinal study. Lancet. 1982;2(8291): 175-179.
26. Miettinen TA, Alfthan G, Huttunen JK, et al. Serum selenium concentration related to myocardial infarction and fatty acid content of serum lipids. Br Med J (Clin Res Ed). 1983; 287(6391):517-519.
27. Salonen JT, Salonen R, Penttila I, et al. Serum fatty acids, apolipoproteins, selenium and vitamin antioxidants and the risk of death from coronary artery disease. Am J Cardiol. 1985;56(4):226-231.
28. Virtamo J, Valkeila E, Alfthan G, et al. Serum selenium and the risk of coronary heart disease and stroke. Am J Epidemiol. 1985;122(2):276-282.
29. Ringstad J, Thelle D. Risk of myocardial infarction in relation to serum concentrations of selenium. Acta Pharmacol Toxicol (Copenh). 1986;59(suppl 7):336-339.
30. Kok FJ, de Bruijn AM, Hofman A, et al. Selenium status and chronic disease mortality: Dutch epidemiological findings. Int J Epidemiol. 1987;16(2):329-332.
31. Ringstad J, Jacobsen BK, Thomassen Y, et al. The Tromsø Heart Study: serum selenium and risk of myocardial infarction a nested case-control study. J Epidemiol Community Health. 1987;41(4):329-332.
32. Suadicani P, Hein HO, Gyntelberg F. Serum selenium concentration and risk of ischaemic heart disease in a prospective cohort study of 3000 males. Atherosclerosis. 1992;96(1): 33-42.
33. Marniemi J, Jarvisalo J, Toikka T, et al. Blood vitamins, mineral elements and inflammation markers as risk factors of vascular and non-vascular disease mortality in an elderly population. Int J Epidemiol. 1998;27(5):799-807.
34. Kilander L, Berglund L, Boberg M, et al. Education, lifestyle factors and mortality from cardiovascular disease and cancer. A 25-year follow-up of Swedish 50-year-old men. Int J Epidemiol. 2001;30(5): 1119-1126.
35. Wei WQ, Abnet CC, Qiao YL, et al. Prospective study of serum selenium concentrations and esophageal and gastric cardia cancer, heart disease, stroke, and total death. Am J Clin Nutr. 2004;79(1):80-85.
36. Akbaraly NT, Arnaud J, Hininger-Favier I, et al. Selenium and mortality in the elderly: results from the EVA study. Clin Chem. 2005;51(11):2117-2123.
37. Bleys J, Miller ER III, Pastor-Barriuso R, et al. Vitamin-mineral supplementation and the progression of atherosclerosis: a meta-analysis of randomized controlled trials. Am J Clin Nutr. 2006;84(4):880-887.
38. Stranges S, Marshall JR, Trevisan M, et al. Effects of selenium supplementation on cardiovascular disease incidence and mortality: secondary analyses in a randomized clinical trial. Am J Epidemiol. 2006; 163(8):694-699.
39. Brown BG, Zhao XQ, Chait A, et al. Simvastatin and niacin, antioxidant vitamins, or the combination for the prevention of coronary disease. N Engl J Med. 2001;345(22):1583-1592.
40. Lippman SM, Goodman PJ, Klein EA, et al. Designing the Selenium and Vitamin E Cancer Prevention Trial (SELECT). J Natl Cancer Inst. 2005;97(2):94-102.
41. Marshall JR, Sakr W, Wood D, et al. Design and progress of a trial of selenium to prevent prostate cancer among men with high-grade prostatic intraepithelial neoplasia. Cancer Epidemiol Biomarkers Prev. 2006; 15(8): 1479-1484.
42. Spallholz JE. On the nature of selenium toxicity and carcino-static activity. Free Radic Biol Med. 1994;17(1):45-64.
43. Spallholz JE, Palace VP, Reid TW Methioninase and selenomethionine but not Se-methylselenocysteine generate methylselenol and superoxide in an in vitro chemiluminescent assay: implications for the nutritional carcinostatic activity of selenoamino acids. Biochem Pharmacol. 2004;67(3): 547-554.
44. Drake EN. Cancer chemoprevention: selenium as a prooxi-dant, not an antioxidant. Med Hypotheses. 2006;67(2): 318-322.
45. Bleys J, Navas-Acien A, Guallar E. Serum selenium and diabetes in U.S. adults. Diabetes Care. 2007;30(4):829-834.
46. Stranges S, Marshall JR, Natarajan R, et al. Effects of long-term selenium supplementation on the incidence of type 2 diabetes: a randomized trial. Ann Intern Med. 2007;147(4): 217-223.
47. Bleys J, Navas-Acien A, Stranges S, et al. Serum selenium and serum lipids in US adults. Am J Clin Nutr. 2008;88(2): 416-423.
48. Mep̈lan C, Crosley LK, Nicol F, et al. Genetic polymorphisms in the human selenoprotein P gene determine the response of selenoprotein markers to selenium supplementation in a gender-specific manner (the SELGEN study). FASEB J. 2007;21(12): 3063-3074.
49. Longnecker MP, Stampfer MJ, Morris JS, et al. A 1-y trial of the effect of high-selenium bread on selenium concentrations in blood and toenails. Am J Clin Nutr. 1993;57(3):408-413.